DUBLIN--(BUSINESS WIRE)--The "Blockchain in Healthcare Market, by Application by End User, by Geography - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023" report has been added to ResearchAndMarkets.com's offering.
The global blockchain in healthcare market is expected to reach $890.5 million by 2023.
This growth is primarily attributed to stringent regulations for safeguarding consumer data, increasing funding and investments in the blockchain arena, and rising adoption of blockchain technology in the healthcare and pharmaceutical industries.
On the basis of application, the blockchain in healthcare market is categorized into clinical data exchange and interoperability, claims adjudication and billing management, drug supply chain management, drug discovery and clinical trials, prescription drug abuse, and others. Among these applications, the market for clinical data exchange and interoperability is expected to reach more than $400 million by 2023, registering a CAGR of over 70%. This can be ascribed to the fact that the blockchain technology can potentially transform the way of clinical information, and data storage and sharing across healthcare partners, payers, and patients.
Based on end user, the blockchain in healthcare market is classified into pharmaceutical companies, healthcare providers, healthcare payers, and others. Healthcare providers, as an end-user category, dominate the market and expected to maintain this trend throughout the forecast period. This can be ascribed to the fact that the blockchain technology is gaining acceptance among healthcare providers, globally. Due to several advantages offered by this technology such as data security and integrity, its adoption is expected to further increase in the coming years.
Geographically, Asia-Pacific (APAC) is anticipated to be the fastest growing blockchain in healthcare market, with at a CAGR of over 70% during the forecast period. This fastest growth is primarily attributed to the growing focus on blockchain technology in this region as well as unmet need in areas of clinical data exchange and interoperability, and drug supply chain management. For example, in July 2018, Singapore Innovate Pte. Ltd. (SGInnovate), Singapore's government-owned technology development firm, invested in MediLOT Technologies, a blockchain and healthcare analytics start-up.
Given the fact that the technology in its nascent stage of development, the companies interested in adopting blockchain technology are partnering and collaborating with various technology providers to exploring the potential applications of the blockchain technology, so that they can streamline their operational processes.
For instance, In January 2018, Guardtime AS, an Estonian blockchain pioneer, finalized a deal with NMC Health, a United Arab Emirates (UAE) based private sector healthcare provider, to bring the technology in the country.
Key Topics Covered
Chapter 1. Research Background
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Technology Insights
4.1 Structure of Blockchain
4.2 Types of Blockchain
4.2.1 Public Blockchain
4.2.2 Private Blockchain
4.2.3 Consortium Blockchain (Permissioned Blockchain)
4.3 Patent Analysis
4.4 Healthcare Blockchain Consortium
4.4.1 Hashed Health Blockchain Consortium
4.4.2 Humana, MultiPlan, Optum, Quest Diagnostics, and UnitedHealthcare Consortium
4.4.3 The MediLedger Project
4.4.4 The HyperLedger Healthcare Working Group (HLHC Working Group)
4.4.5 My Health My Data (MHMD)
4.4.6 Enterprise Ethereum Alliance (EEA)
Chapter 5. Investment and Funding Scenario
Chapter 6. Introduction
6.1 Definition of Market Segments
6.1.1 By Application
188.8.131.52 Clinical data exchange and interoperability
184.108.40.206 Claims adjudication and billing management
220.127.116.11 Drug supply chain management
18.104.22.168 Drug discovery and clinical trials
22.214.171.124 Prescription drug abuse
6.1.2 By End User
126.96.36.199 Pharmaceutical companies
188.8.131.52 Healthcare providers
184.108.40.206 Healthcare payers
6.2 Market Dynamics
220.127.116.11 Increasing number of partnerships and collaborations
18.104.22.168 Increasing number of regulations for safeguarding consumer data
22.214.171.124 Growing funding and investments in the blockchain technology
126.96.36.199 Implementation of blockchain in pharmaceutical supply chain
188.8.131.52 Impact analysis of drivers on market forecast
184.108.40.206 Lack of awareness about blockchain technology
220.127.116.11 Implementation related challenges
18.104.22.168 Establishing a clear return on investment (ROI) from blockchain technology
22.214.171.124 Regulatory hurdles
126.96.36.199 Impact analysis of restraints on market forecast
188.8.131.52 Need for better management of medical data
184.108.40.206 Increasing incidence of healthcare data breaches and growing threat of substandard counterfeit drugs
6.3 Porter's Five Forces Analysis
Chapter 7. Global Market Size and Forecast
Chapter 8. North America Market Size and Forecast
Chapter 9. Europe Market Size and Forecast
Chapter 10. APAC Market Size and Forecast
Chapter 11. LATAM Market Size and Forecast
Chapter 12. MEA Market Size and Forecast
Chapter 13. Strategic Developments
13.1 Mergers and Acquisitions
13.2 Product Launches
13.3 Partnerships, Agreements and Collaborations
13.4 Geographic Expansions
13.5 Other Developments
Chapter 14. Company Profiles
- International Business Machines Corporation
- Microsoft Corporation
- Guardtime AS
- PokitDok Inc.
- Hashed Health
- iSolve LLC
- Patientory Inc.
- Factom Inc.
- Chronicled Inc.
- Accenture PLC
- DeepMind Technologies Limited
- Doc.ai Inc.
- Coral Health Research & Discovery Inc.
For more information about this report visit https://www.researchandmarkets.com/r/f9m555